en

PRODUCT DETAIL

Zetovar 10 mg/80 mg tablety

Code 2516D
MA number 31/0295/19-S
Product Form: tbl 30x10 mg/80 mg (blis.OPA/Al/PVC)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 31 - HYPOLIPIDAEMICA
ATC:
C CARDIOVASCULAR SYSTEM
C10 Lipid modifying agents
C10B Lipid modifying agents, combinations
C10BA HMG CoA reduct. inhib in conbinat. w. ot. lip. modifying agents
C10BA05 Atorvastatin and ezetimibe
Shelf life: 24
Container: blister OPA/Al/PVC
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10b fixed combination application
MA issued: 26.09.2019
Validity: 26.09.2024
PIL: PIL_Zetovar tablety_05.2022.pdf  
SPC: SPC_Zetovar tablety_05.2022.pdf  
Safety feature Yes
Data update: 27.09.2019
eu-flag.png sk-flag.png